NYTech
Companies
Companyhealthcare ai

EIGEN Bio

Eigen Bio is a biological intelligence company that models the causal logic of biology to predict disease, treatment response, drug targets, and biomarkers. Its platform combines a biological foundation model, Eigen-1, with a multi-omics knowledge graph, Eigenfield. The commercial offering, Eigen ORIGIN, deploys the platform inside customer environments for target and biomarker discovery.[1][2]

Visit website Suggest an update
8 People on the graph

Overview

Eigen Bio is a biological intelligence company operating in the New York City artificial intelligence sector [1][2]. The company models the causal logic of biology to predict disease, treatment response, drug targets, and biomarkers [2]. Its platform combines a biological foundation model called Eigen-1 with a multi-omics knowledge graph named Eigenfield [2]. The commercial offering, Eigen ORIGIN, deploys the platform inside customer environments for target and biomarker discovery [2]. As of the available data, Eigen Bio operates in the biotechnology research industry [3].

Growth & traction

LinkedIn lists 8 people working at EIGEN Bio. [4]

Leadership & org chart

Focus

  • EIGEN Bio describes itself as "Building the regulatory model of human biology that predicts mechanism, response, and biomarkers.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.